Pfs25M-EPA/AS01

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePfs25M-EPA/AS01

Drug Alias NamePfs25M-EPA/AS01 (NIAID)PpPfs25/ISA51transmission blocking protein subunit vaccine (NIAID)ScPvs25/ISA51P47-targeting transmission-blocking vaccine (NIAID)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMalaria, VivaxMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesMali

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Inactive CompaniesNational Institutes Of Health

Active IndicationsMalaria

Inactive IndicationsMalaria, Vivax

Other Information

ATC CodeN/A